Please login to the form below

Not currently logged in

Tizona Therapeutics

This page shows the latest Tizona Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Gilead agrees $21bn buyout of Immunomedics

Gilead agrees $21bn buyout of Immunomedics

Gilead has been bolstering its oncology portfolio over the course of this year, with prior deals including a play for Tizona Therapeutics and its lead antibody candidate, as well as its

Latest news

  • Gilead makes a play for novel cancer drug with Tizona deal Gilead makes a play for novel cancer drug with Tizona deal

    Pharma company continues oncology biotech spending spree. Gilead has made a play for another small oncology specialist, Tizona Therapeutics, as it continues its foray into the immunotherapy research and development space. ... Tizona is also set to

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....